ライフサイエンスコーパス: intra-abdominal

1 ions were the most common (64%), followed by intra-abdominal (26%), orthopaedic (6%), and tropical in

2 roparesis, intra-abdominal fluid collection, intra-abdominal abscess (10% vs 25%, P = 0.027), severe

3 after 90 days included wound infections and intra-abdominal abscess (n = 75) and failure to thrive (

4 (OR, 4.90; 95% CI, 1.41-17.06; P = .01) and intra-abdominal abscess (OR, 7.46; 95% CI, 1.65-33.66; P

5 The third complication was an intra-abdominal abscess after a TV appendectomy.

6 linical symptoms and signs of peritonitis or intra-abdominal abscess and isolation of Candida species

7 s, and postoperative complications including intra-abdominal abscess and pancreatic fistula (all P <

8 OR], 0.93; 95% CI, 0.38-2.32; P = .88) or on intra-abdominal abscess development (OR, 0.89; 95% CI, 0

9 .093), postoperative hemorrhage (P = 0.174), intra-abdominal abscess formation (P = 0.199), biliary l

10 vitro and in vivo they were attenuated in an intra-abdominal abscess infection model.

11 s necessary for maximal virulence in a mouse intra-abdominal abscess model.

12 With CPG-directed care, intra-abdominal abscess rate decreased from 0.24 to 0.10

13 Patients who had an anastomotic leak or intra-abdominal abscess were included in the infection g

14 ndpoints were postoperative wound infection, intra-abdominal abscess, reoperation, length of hospital

15 ndpoints were postoperative wound infection, intra-abdominal abscess, reoperation, length of hospital

16 f surgery and postoperative wound infection, intra-abdominal abscess, reoperation, or readmission.

17 f surgery and postoperative wound infection, intra-abdominal abscess, reoperation, or readmission.

18 ileostomy closure (6.5%), trauma (2.7%), and intra-abdominal abscess/other peritonitis (1.9%).

19 r IBD recurrence (n = 66, 12%) or because of intra-abdominal-abscess or fistula (n = 93, 16%).

20 There were no intra-abdominal abscesses or other major complications a

21 RIM101 contributes to persistence within intra-abdominal abscesses, at least in part through acti

22 x inflammation did LA significantly increase intra-abdominal abscesses.

23 RT was longer in patients with intra-abdominal adhesions (P = 0.0139) and higher BMI (P

24 bilization, is unaffected by the presence of intra-abdominal adhesions, and is possible in obese pati

25 The link between intra-abdominal adiposity and type II diabetes has been

26 reased cardiorespiratory fitness and reduced intra-abdominal adiposity are not invariably associated

27 PRA is safe, avoids intra-abdominal adjacent organ mobilization, is unaffect

28 fat by dual-energy X-ray absorptiometry and intra-abdominal and subcutaneous abdominal adipose tissu

29 podystrophy that is characterized by loss of intra-abdominal and subcutaneous white fat, severe insul

30 ty are tied to location of excess fat in the intra-abdominal as compared to subcutaneous white adipos

31 erated in a randomized order by inflating an intra-abdominal balloon.

32 aks (1.0%), which responded to drainage, and intra-abdominal bleeding (n = 3), splenectomy (n = 1), a

33 lications (new-onset multiple organ failure, intra-abdominal bleeding, enterocutaneous fistula, or pa

34 race, cigarette smoking, and obesity with an intra-abdominal body fat distribution.

35 instruments, retractors, and a controllable intra-abdominal camera.

36 and found to exhibit improved inhibition of intra-abdominal cancer in two clinically relevant murine

37 The spread of intra-abdominal cancers is a vexing clinical problem for

38 We studied the pathogenesis of intra-abdominal candidiasis (IAC) in mice that were infe

39 % CI, 1.45-7.93; p = 0.005) or occurrence of intra-abdominal candidiasis (tumor necrosis factor-alpha

40 tor-alpha and an increased susceptibility to intra-abdominal candidiasis in a homogenous prospective

41 The pathogenesis of intra-abdominal candidiasis is poorly understood.

42 A mouse model of intra-abdominal candidiasis is valuable for studying pat

43 Intra-abdominal candidiasis was defined by the presence

44 101 influenced expression of 49 genes during intra-abdominal candidiasis, including previously uniden

45 with significant increases in alimentary and intra-abdominal cases.

46 ss are in the abdominal wall followed by the intra-abdominal cavity, usually in the sub-hepatic or re

47 bolic syndrome with an increase in visceral (intra-abdominal) compared to subcutaneous fat.

48 In MCS, intracranial, intrathoracic and intra-abdominal compartment pressures are interrelated.

49 ; 95% confidence interval (CI): 1.06-24.71], intra-abdominal complications (OR: 3.46; 95% CI: 1.49-8.

50 ivity in adipose tissue, particularly in the intra-abdominal depot, that are regulated by physiologic

51 is composed of both subcutaneous and several intra-abdominal depots.

52 We then established that localized intra-abdominal desensitization of TRPV1 channels with i

53 al of patients with stage I, II, III, and IV intra-abdominal desmoid tumor were 95%, 100%, 89%, and 7

54 system to predict mortality in patients with intra-abdominal desmoid tumors and identified additional

55 evaluate the mortality rate of patients with intra-abdominal desmoid tumors and to identify prognosti

56 INTRODUCTION: Intra-abdominal desmoid tumors are one of the leading ca

57 A total of 154 patients with intra-abdominal desmoid tumors were included in the stud

58 , elevated body mass index, tobacco use, and intra-abdominal distribution of fat) to detect esophagea

59 There is considerable uncertainty regarding intra-abdominal drainage after pancreatoduodenectomy.

60 Omission of drains was not inferior to intra-abdominal drainage in terms of postoperative reint

61 eaticojejunal anastomosis were randomized to intra-abdominal drainage versus no drainage.

62 Omental milky spots readily concentrate intra-abdominal E. coli where macrophages and recruited

63 A libraries from murine subcutaneous (SC) or intra-abdominal epididymal (EP) white adipocytes.

64 Mouse islets engrafted on the intra-abdominal epididymal fat pad ameliorated streptozo

65 y derived from lipolysis of intrahepatic and intra-abdominal fat and de novo lipogenesis.

66 Both baseline intra-abdominal fat area (P = 0.002) and HOMA-IR (P < 0.

67 Visceral adiposity was measured as intra-abdominal fat area at the umbilicus level.

68 Intra-abdominal fat area remained a significant predicto

69 fat area was defined as total fat area minus intra-abdominal fat area.

70 A-IR at 10-11 years in models that contained intra-abdominal fat area.

71 Other measures included subcutaneous and intra-abdominal fat from computed tomography scans, weig

72 s to decreased ovarian reserve and increased intra-abdominal fat mass in granddaughters, accompanied

73 ditional port placement because of excessive intra-abdominal fat or limited abdominal domain.

74 Changes in weight and intra-abdominal fat were not significantly different bet

75 0.0001), colorectal cancer (P < 0.0001) and intra-abdominal fistula (P < 0.0001), but not older than

76 ge was associated with a higher incidence of intra-abdominal fluid collection (9% vs 22%, P = 0.0004)

77 ed with a higher incidence of gastroparesis, intra-abdominal fluid collection, intra-abdominal absces

78 ients with blood, bronchoalveolar lavage, or intra-abdominal fluid cultures growing Enterobacter spp,

79 in the control group had minimal amounts of intra-abdominal free fluid.

80 animals dying uniformly at birth of massive intra-abdominal hemorrhage.

81 and physiologic disruptions associated with intra-abdominal HIPEC is critical to ensure effective an

82 15 mm Hg), and simultaneous pleural effusion/intra abdominal hypertension.

83 Air-regulated intra-abdominal hypertension (0-25 mm Hg).

84 al pleural effusion instillation (13 mL/kg), intra-abdominal hypertension (15 mm Hg), and simultaneou

85 considered mostly a postsurgical condition, intra-abdominal hypertension (IAH) and the abdominal com

86 ond, and third time periods (p < 0.001), and intra-abdominal hypertension (intra-abdominal pressure >

87 with at least one additional risk factor for intra-abdominal hypertension (multiple trauma, abdominal

88 and DP(TP) were increased by the presence of intra-abdominal hypertension (p < 0.0001 and p = 0.0222,

89 sion was 29.8% versus 18.6% in those without intra-abdominal hypertension (p < 0.001).

90 phylactic use of the open abdomen to prevent intra-abdominal hypertension after DC laparotomy.

91 The diagnosis and management of intra-abdominal hypertension and abdominal compartment s

92 n often effectively affect lesser degrees of intra-abdominal hypertension and abdominal compartment s

93 ) and lung compliance (C(L)), in response to intra-abdominal hypertension and changes in positive end

94 Intra-abdominal hypertension decreased end-expiratory lu

95 Intra-abdominal hypertension decreased end-expiratory tr

96 Intra-abdominal hypertension decreased total respiratory

97 During bilateral lung injury, intra-abdominal hypertension increased both DP(AW) (at p

98 pared with normal intra-abdominal pressures, intra-abdominal hypertension increased DP(AW), during bo

99 Intra-abdominal hypertension is common in critically ill

100 patients allows for sufficient detection of intra-abdominal hypertension is unclear.

101 Relief of intra-abdominal hypertension may be instrumental to the

102 Intra-abdominal hypertension may contribute to a poor ou

103 The presence of intra-abdominal hypertension negates most of the positiv

104 early abdominal decompression for refractory intra-abdominal hypertension or abdominal compartment sy

105 The mortality of patients with intra-abdominal hypertension was 29.8% versus 18.6% in t

106 ural effusion was present and by 184 mL when intra-abdominal hypertension was present.

107 When pleural effusion and intra-abdominal hypertension were simultaneously applied

108 abdominal pressure and to aggressively treat intra-abdominal hypertension when identified.

109 In a pig model of intra-abdominal hypertension, positive end-expiratory pr

110 ng results in an increased detection rate of intra-abdominal hypertension.

111 end-expiratory lung volume decline caused by intra-abdominal hypertension.

112 ions does not increase the detection rate of intra-abdominal hypertension.

113 udy period, the use of a continually revised intra-abdominal hypertension/abdominal compartment syndr

114 at risk significantly improves survival from intra-abdominal hypertension/abdominal compartment syndr

115 of an open abdomen to prevent development of intra-abdominal hypertension/abdominal compartment syndr

116 nd LOS, 30-day readmission rates, ileus, and intra-abdominal infection (all P's > .05).

117 in the 0- to 12-month postsurgery period for intra-abdominal infection (aOR, 2.09 [95% CI, 1.78-2.46]

118 ting than procalcitonin for the detection of intra-abdominal infection (areas under the ROC curve: 0.

119 onal Consensus Criteria) due to pneumonia or intra-abdominal infection (cohorts 1-3, n=2534 patients)

120 of morbidity after liver transplantation is intra-abdominal infection (IAI) about which there are li

121 el of Candida albicans-Staphylococcus aureus intra-abdominal infection (IAI) results in 100% mortalit

122 al of short-course antimicrobial therapy for intra-abdominal infection (STOP-IT), and results suggest

123 erative days 2, 3, 4, and/or 5 as markers of intra-abdominal infection after elective colorectal surg

124 nia, 112 for urinary tract infection, 83 for intra-abdominal infection and 45 for bloodstream infecti

125 ned as reinsertion of nasogastric tube), and intra-abdominal infection and association between colore

126 te marker for the detection of postoperative intra-abdominal infection and the appropriate moment to

127 ased after bariatric surgery whereas that of intra-abdominal infection and UTI increased.

128 going emergency gastrointestinal surgery for intra-abdominal infection are at risk of invasive candid

129 nflammatory cytokine production during acute intra-abdominal infection caused by cecal ligation and p

130 cated urinary tract infection or complicated intra-abdominal infection caused by ceftazidime-resistan

131 Intra-abdominal infection decreased from 7.4% to 2.5% (P

132 cated urinary tract infection or complicated intra-abdominal infection due to ceftazidime-resistant G

133 el of Staphylococcus aureus-Candida albicans intra-abdominal infection results in approximately 60% m

134 The incidence of intra-abdominal infection was 11.8%, with 24.6% of patie

135 en patients with sepsis due to pneumonia and intra-abdominal infection were combined.

136 ep-/-)) mice were generated and subjected to intra-abdominal infection with Klebsiella pneumoniae, wh

137 ary tract infection and ten with complicated intra-abdominal infection) and 148 assigned to best avai

138 nary tract infection and 11 with complicated intra-abdominal infection) were analysed for the primary

139 cus on one site of infection (eg, pneumonia, intra-abdominal infection).

140 ause invasive disease, such as endocarditis, intra-abdominal infection, and shock.

141 sue infection (SSTI), respiratory infection, intra-abdominal infection, or urinary tract infection (U

142 ive care unit patients requiring surgery for intra-abdominal infection.

143 clinical trials in patients with complicated intra-abdominal infections (cIAI).

144 sistance among pathogens causing complicated intra-abdominal infections (cIAIs) supports the developm

145 adult hospitalized patients with complicated intra-abdominal infections (cIAIs).

146 Intra-abdominal infections (IAIs) after elective colorec

147 ted urinary tract infections and complicated intra-abdominal infections (when used with metronidazole

148 egarding the risk of increased postoperative intra-abdominal infections after laparoscopic appendecto

149 ble outcome in community-acquired pneumonia, intra-abdominal infections and bloodstream infections, r

150 Intra-abdominal infections are common in young infants a

151 Intra-abdominal infections are frequent and life-threate

152 Intra-abdominal infections are one of the most common in

153 as highest during natural disaster missions, intra-abdominal infections during hospital support missi

154 penem in 1066 men and women with complicated intra-abdominal infections from 2 identical, randomized,

155 <91 days of age with suspected or confirmed intra-abdominal infections hospitalized in 24 neonatal i

156 linical trials of antibiotics in complicated intra-abdominal infections identified through systematic

157 life-threatening disease via bloodstream and intra-abdominal infections in immunocompromised and tran

158 tibiotic therapy for patients with localized intra-abdominal infections ranging from mild to moderate

159 ls of 5 anti-infective agents in complicated intra-abdominal infections used a source control review

160 ere minor (76%), whereas most operations for intra-abdominal infections were major (98%).

161 Retransplantation and intra-abdominal infections were major risk factors.

162 acy of Ceftolozane/Tazobactam in Complicated Intra-abdominal Infections) was a prospective, randomize

163 n (eg, complicated urinary tract infections, intra-abdominal infections), yet these designs may not b

164 In clinical trials of complicated intra-abdominal infections, assessment of adequacy of th

165 al superiority of short-duration therapy for intra-abdominal infections.

166 atients: 10 with wound infections and 2 with intra-abdominal infections.

167 t activity against pathogens associated with intra-abdominal infections.

168 to meropenem in the treatment of complicated intra-abdominal infections.

169 young infants with suspected or complicated intra-abdominal infections.

170 be a useful adjunct in treating hepatic and intra-abdominal infections.

171 k surgical intensive care unit patients with intra-abdominal infections.

172 biofilms in the gastrointestinal tract, and intra-abdominal infections.

173 rganisms were experimentally challenged with intra-abdominal injections of bacteria.

174 hic imaging associated with the diagnosis of intra-abdominal injuries (IAI), as well as review the cu

175 ho require further diagnostic evaluation for intra-abdominal injuries after blunt abdominal trauma.

176 ted tomographic (CT) scans in the ED, missed intra-abdominal injuries, ED length of stay, and hospita

177 %, 95% CI, 4.0% to 7.1%) were diagnosed with intra-abdominal injuries, including 40 (80%; 95% CI, 66%

178 use of resources; ED length of stay; missed intra-abdominal injuries; or hospital charges.

179 tenderness to palpation does not rule out an intra-abdominal injury (summary LR, 0.61; 95% CI, 0.46-0

180 The prevalence of intra-abdominal injury in adult emergency department pat

181 Test results increasing the likelihood of intra-abdominal injury include a base deficit less than

182 One case of missed intra-abdominal injury occurred in a patient in the FAST

183 f variables for identifying patients without intra-abdominal injury requires further study.

184 included studies of diagnostic accuracy for intra-abdominal injury that compared at least 1 finding

185 Clinical decision rules are able to predict intra-abdominal injury with high sensitivity.

186 For detection of intra-abdominal injury, FAST sensitivity (Sn) was 0.56,

187 arotomy, autopsy, and/or clinical course for intra-abdominal injury.

188 gs, but a normal result does not rule out an intra-abdominal injury.

189 arding (LR, 3.7; 95% CI, 2.3-5.9) suggest an intra-abdominal injury.

190 igs (49.6 +/- 5.8 kg) underwent laparoscopic intra-abdominal insufflation with 14 mm Hg CO2 gas for 6

191 These results suggest a unique intra-abdominal interaction between the host and C. albi

192 pulmonary embolism (11), pneumonia (13), and intra-abdominal lesions (16).

193 (P = .01), blood in the stool (P = .04), and intra-abdominal lymph nodes (P = .001).

194 who developed metastases in the inguinal and intra-abdominal lymph nodes and thigh muscles.

195 of the primary tumor and for the presence of intra-abdominal metastases.

196 months post-LTx and other developed de novo intra-abdominal metastatic adenocarcinoma of unknown ori

197 PMC is a rare, malignant, intra-abdominal neoplasm that produces large amounts of

198 We studied 618,495 patients who underwent an intra-abdominal operation from the National Inpatient Sa

199 ases declined steadily, while alimentary and intra-abdominal operations increased.

200 S) is a surgical concept permitting scarless intra-abdominal operations through natural orifices, suc

201 and major liver resections, even with prior intra-abdominal operations, in selected patients and whe

202 inical syndrome characterized by progressive intra-abdominal organ dysfunction resulting from elevate

203 levated IAP (>or=8 mm Hg) is associated with intra-abdominal organ dysfunction.

204 o the upper body parts at the expense of the intra-abdominal organs associated only with a smaller co

205 o the upper body parts at the expense of the intra-abdominal organs.

206 Damage control (DC) with intra-abdominal packing and delayed reconstruction is an

207 RESEARCH DESIGN AND Adipocytes from intra-abdominal/perigonadal (PG) and subcutaneous (SC) a

208 dressed the BCRA1/2 carrier lifetime risk of intra-abdominal peritoneal carcinoma from an appendix so

209 ian, non-fallopian tube, nonbreast, positive intra-abdominal peritoneal carcinoma in previously cance

210 In females, intra-abdominal PG adipocytes are more insulin-sensitive

211 y of C. albicans to induce mortality from an intra-abdominal polymicrobial infection.

212 Intra-abdominal polymicrobial infections cause significa

213 Intra-abdominal polymicrobial infections cause significa

214 -ligation and puncture (CLP) model to induce intra-abdominal polymicrobial peritonitis, we recently e

215 < 0.001), and intra-abdominal hypertension (intra-abdominal pressure >/= 12 mm Hg) occurred in 19.9%

216 Four levels of intra-abdominal pressure (baseline, 12, 18, and 22 mm Hg

217 Elevated intra-abdominal pressure (IAP) is a frequent cause of mo

218 Elevated intra-abdominal pressure (IAP) is associated with ICP el

219 is considered the gold standard for indirect intra-abdominal pressure (IAP) measurements.

220 study sought to determine whether changes in intra-abdominal pressure (IAP) with aggressive diuretic

221 d can be present at relatively low levels of intra-abdominal pressure (IAP).

222 Above intra-abdominal pressure 5 mm Hg, plateau airway pressur

223 dal ventilation in the presence of increased intra-abdominal pressure and in calculating true transpu

224 cs, and cardiac output 5 mins after each new intra-abdominal pressure and positive end-expiratory pre

225 to minimize the risk of developing elevated intra-abdominal pressure and to aggressively treat intra

226 as well as minimization of intrathoracic and intra-abdominal pressure as clinically possible.

227 The mean intra-abdominal pressure at admission day was an indepen

228 city was significantly reduced by increasing intra-abdominal pressure at both positive end-expiratory

229 ry lung volume (+119% [p < .001] at 22 mm Hg intra-abdominal pressure compared with 5 cm H2O positive

230 ry lung volume (+233% [p < .001] at 22 mm Hg intra-abdominal pressure compared with 5 cm H2O positive

231 and -8% [p < .05], respectively, at 22 mm Hg intra-abdominal pressure compared with baseline intra-ab

232 High intra-abdominal pressure could enhance the penetration o

233 njury and acute renal failure with regard to intra-abdominal pressure dynamics, preload limitation, a

234 ate positive end-expiratory pressure (= half intra-abdominal pressure in cm H2O + 5 cm H2O), and high

235 and high positive end-expiratory pressure (= intra-abdominal pressure in cm H2O).

236 positive end-expiratory pressure matched to intra-abdominal pressure led to a preservation of end-ex

237 ivided into three subgroups according to the intra-abdominal pressure measurement policy in different

238 Intra-abdominal pressure measurements in predefined at-r

239 dent predictor of mortality in patients with intra-abdominal pressure measurements started within the

240 Whether limiting intra-abdominal pressure measurements to preselected at-

241 Serial intra-abdominal pressure measurements, nonoperative pres

242 We aimed to clarify whether expanded intra-abdominal pressure monitoring results in an increa

243 In patients with intra-abdominal pressure monitoring, the mean intra-abdo

244 tudied, and 1,241 patients (46.0%) underwent intra-abdominal pressure monitoring.

245 hing positive end-expiratory pressure to the intra-abdominal pressure on cardio-respiratory parameter

246 ntra-abdominal pressure monitoring, the mean intra-abdominal pressure on the admission day is an inde

247 cy of this condition, routine measurement of intra-abdominal pressure should be performed in high-ris

248 Expanding the measurement of intra-abdominal pressure to more than 50% of intensive c

249 positive end-expiratory pressure matched to intra-abdominal pressure to prevent intra-abdominal pres

250 cted by opening the abdomen, suggesting that intra-abdominal pressure transmission contributes little

251 e increased linearly by ~ 50% of the applied intra-abdominal pressure value, associated with commensu

252 The intra-abdominal pressure was measured in 31.7%, 55.6%, a

253 ra-abdominal pressure compared with baseline intra-abdominal pressure) but did not change cardiac out

254 pressure is the gold standard for measuring intra-abdominal pressure, and several nonsurgical method

255 us, elevated intracranial pressure, elevated intra-abdominal pressure, and therapeutic hypothermia af

256 Indeed, increased intra-abdominal pressure, as an extreme marker of abdomi

257 ission to the ICU was associated with higher intra-abdominal pressure, higher plasma C reactive prote

258 At each level of intra-abdominal pressure, moderate positive end-expirato

259 The detrimental impact of elevated intra-abdominal pressure, progressing to abdominal compa

260 t fluid, blood and protein losses, increased intra-abdominal pressure, systemic hyperthermia, and inc

261 At each level of intra-abdominal pressure, three levels of positive end-e

262 ring laparoscopic surgery produces increased intra-abdominal pressure, which potentially influences h

263 tched to intra-abdominal pressure to prevent intra-abdominal pressure-induced end-expiratory lung vol

264 al reflux, which may be related to increased intra-abdominal pressure.

265 s occurred in transpulmonary pressure due to intra-abdominal pressure.

266 utes to continence during rapid increases in intra-abdominal pressure.

267 al organ dysfunction resulting from elevated intra-abdominal pressure.

268 arying degrees of matching the corresponding intra-abdominal pressure: baseline positive end-expirato

269 anges in positive end-expiratory pressure or intra-abdominal pressures in both conditions.

270 Application of intra-abdominal pressures of 0 and 20 cm H2O at positive

271 ethysmography (OEP), (ii) intra-thoracic and intra-abdominal pressures with a balloon catheter in eac

272 When compared with normal intra-abdominal pressures, intra-abdominal hypertension

273 cent graduates averaged 80 alimentary and 78 intra-abdominal procedures during their CR years.

274 surgically treated IH after 12,000 elective, intra-abdominal procedures to provide more individualize

275 75 mm; P = .008); its length correlated with intra-abdominal (R = 0.35; P = .045) and total abdominal

276 five adults with abdominal injury (46.7%) or intra-abdominal sepsis (52.3%) were randomly allocated t

277 temic inflammation after abdominal injury or intra-abdominal sepsis is associated with poor outcomes.

278 al responses in the context of pneumonia and intra-abdominal sepsis than wild-type animals.

279 In murine intra-abdominal sepsis, pulmonary injury cannot be consi

280 4 mo) mice underwent a cecal slurry model of intra-abdominal sepsis.

281 PS, bacterial lipopeptide, and polymicrobial intra-abdominal sepsis.

282 (ECF), enteroatmospheric fistula (EAF), and intra-abdominal sepsis/abscess (IAS) are major challenge

283 s with severe (n = 21) or non-severe (n = 8) intra-abdominal sepsis; severe (n = 23) or non-severe (n

284 rats, splenorenal shunts (the most prominent intra-abdominal shunts) of BDL rats, and mesentery of sh

285 multiple organ failure and in patients with intra-abdominal sources of sepsis.

286 d), and Metastatic (cells implanted on other intra-abdominal surfaces).

287 trol group of patients without HAP following intra-abdominal surgery (mortality = 1.2%) (P < 0.001).

288 n for matched pairs showed that a history of intra-abdominal surgery (odds ratio [OR] = 2.865; 95% co

289 ntrolled trials in patients undergoing major intra-abdominal surgery have challenged the historical u

290 Of the 13,292 patients with HAP following intra-abdominal surgery, 1421 died prior to discharge (m

291 to collect data from 50 patients undergoing intra-abdominal surgical interventions [40 men, 10 women

292 All intra-abdominal, surgical site, or skin/skin structure i

293 A total of 4178 intra-abdominal, surgical site, or skin/skin structure i

294 ponse was not affected by desensitization of intra-abdominal TRPV1 receptors with resiniferatoxin (20

295 Intra-abdominal tumors, such as ovarian cancer, have a c

296 Intra-abdominal volume increased significantly after sep

297 Intra-abdominal volumes were prospectively measured befo

298 arance and intense mitochondrial staining in intra-abdominal WAT suggest significant 'browning', but

299 ing that DKO mice may become more reliant on intra-abdominal WAT to supply lipid for oxidation.

300 Analysis of intra-abdominal white adipose tissue (epididymal WAT) sh

301 1% reduction in TFAM in the subcutaneous and intra-abdominal white adipose tissue (WAT) and interscap